chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was to receive first dose of Pfizer COVID-19 vaccine. Administrator pulled up the diluent amount of 1.3mL and 0.2mL of the Pfizer vaccine medication into the same syringe, and administered to the patient for a total of 1.5mL. The diluent of 1.3mL should have been injected into the Pfizer vaccine vial. 0.2 mL should have been drawn-up to administer to the patient.
Patient begin to experience throat tightening, sensation of need to clear throat frequently,  voice hoarseness, trouble swallowing, choking sensation and headache 45 minutes after receiving 2nd moderna vaccine.   Patient took Benadryl 50 mg OTC and went to ED.  Treated with racemic epinephrine, IV benadyl, IV decadron, IV pepcid.  Given script for epipen by ED provider, but has not needed to use.
Immediately felt dizzy, got pale, started shaking. BP and pulse was extremely high, around 220/178 and 130. Over the course of an hour and a half BP slowly went down. Continued to shake uncontrollably from head to toe for two hours. BP and pulse stayed high for 5 to 6 hours. Feel fine afterwards.
I developed a severe rash on the left side of my chest and left arm. Diagnosed as shingles after a night in the hospital.
Vaccine that administered beyond use date after the thaw process/expired vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported. It was unknown if the patient had ever been diagnosed with or tested positive for COVID-19. It was unknown if the patient had any acute illness at the time of vaccination and up to one month before. It was also unknown if the patient had any chronic or long-standing health conditions.  Vaccine Ndc code was reported as 80777-0273-99.  The patient did not experience any adverse reactions after the administration of vaccine.  No treatment information was provided by the reporter.
Got cellulitis on R thigh at site of injection. Had to go to ER got 3 days of IV antibiotics follow by oral antibiotics.
Extreme itching and red areas on torso. Stopped in 48 hours. Then 8 days after shot, flashes of nerve pain in left upper arm (like electric shock). Then 10 days after shot, this flash of "electric" pain has occurred across the top of left foot.
Since receiving the vaccination, I have been extremely tired and have headaches above my ears. I have never been this tired, every day.
On the evening of 4/15/21, 14 days after receiving my 2nd Moderna vaccine on 4/1/21, I developed chills, fever 99.3 F,  muscle aches, and severe bi-temporal headache.  This lasted for 24 hours and resolved spontaneously.  I had the identical symptoms 4/2/21 the day after receiving my vaccine, also resolving within 24 hours.  I tested negative for rapid covid testing on 4/16/21.  I am reporting this because I am not able to find reports of vaccine reactions two weeks post injection when I look on line or ask colleagues, and I wonder if this has been reported.
PT BECAME PALE AND FAINTED, FALLING FOrward OUT OF CHAIR AND HITTING HEAD ON FLOOR. SCRATHES AND BUMP Appeared on forehead. ice packs were applied to back of neck after sitting patient on floor , leaning against chair. pt sat for several minutes and felt better so she left.
I experienced issues breathing on 10/29/2021 fours weeks after receiving the vaccine and had to go to urgent care. The doctor diagnosed my symptoms as Bronchitis and prescribed a Z-Pack for 5 days. I was also given a COVID test which came back negative.
Fever, flu-like symptoms, achy, arm pain with slight redness (half dollar).
the left shoulder/deltoid area was firm, swollen, and warm to touch. Patient reports pain 2/10 when nothing is touching it, and 7/10 when the area is touched.
Patient awoke the morning following the vaccination experiencing double vision, difficulty focusing vision.  He presented to opthalmologist on 1/30/21 and was diagnosed with a L 6th nerve palsy.  His symptoms have persisted and are accompanied by a HA.
On 3/1/2023 - Patient in to discuss a rash she had after receiving her immunizations on 2/15/2023. Later that day and the next day, she had a rash on her forearms and her legs, but very slight rash on her arms at the injection site. She also had her lips to swell with itching. She used some Benadryl for a few days with improvement. Last night she had itching on the soles of her feet and the palms of her hands. Today, the only visible rash is on her forearms and that looks dry and darker discolored, not a current looking inflammation process.
Itching and burning of left corner of right eye. Next day 01/08 numbness, burning and tingling of right front scalp, right forehead, eyelid corner, and top of right ear.  Jabbing pain caused me to contact nurse who made an appt for 01/09/2012 at 10:40 AM.  Diagnosed with Shingles of the 3rd facial nerve.  Started anti-viral at 11:00 AM.  Slight rash, fever, headache, diarrhea and malaise on afternoon and evening of 01/09/2012.
SLEEP MORE THAN USUAL; CHILLS; STABBING JOINT PAIN; FEVER; This spontaneous report received from a consumer concerned a 40 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 16-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included salbutamol for asthma. On 16-AUG-2021, the patient experienced sleep more than usual. On 16-AUG-2021, the patient experienced chills. On 16-AUG-2021, the patient experienced stabbing joint pain. On 16-AUG-2021, the patient experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sleep more than usual, and stabbing joint pain, and the outcome of fever and chills was not reported. This report was non-serious.
No immediate reaction but 5 days later (April 1) lymph nodes on neck were painful but went away after a day. But nausea and loss of appetite which started 5 days later on April 1 still remain as of today 4/7.  It doesn't prevent me from eating or any other problems just definitely not myself.     What's even more strange is my desire to drink 7up because of feeling sick. Haven't drank this stuff in over 30 years. But the feeling of nausea triggered past memoires of drinking 7up to feel better.
Information has been received from the mother of a 13 month old female with no relevant medical history who on 09/08/03 was vaccinated with a dose of varicella virus vaccine live.  On approximately 08/30/03, concomitant medication included amoxicillin. At the time of vaccination the child had a "febrile respiratory infection" which had begun the weekend of 08/30/03 to 08/31/03.  On 09/09/03, the pt began to develop a rash on her legs, arms, face, abdomen and back. On approximately 09/25/03, it was noted that the rash had "changed to blisters now", with "50+ lesions". It was also noted that she developed a red mark at the injection site. There were no lab diagnostic studies performed. The physician had been contacted. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
High fever (102.5)and general malaise beginning this morning. Arm quite sore beginning yesterday.   High fever continuing27 hrs after dose
Pain in lungs, side of lungs to back of lungs; Hard to breathe, started after getting the vaccine; After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso; Recently been coughing; The pain moves around, I didnt have it before the vaccine; After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso; when breathe it hurts; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Pain in lungs, side of lungs to back of lungs), DYSPNOEA (Hard to breathe, started after getting the vaccine), ABDOMINAL PAIN (After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso), COUGH (Recently been coughing) and PAIN (The pain moves around, I didnt have it before the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21D and 022B1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO medical history is provided by reporter.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (Pain in lungs, side of lungs to back of lungs), DYSPNOEA (Hard to breathe, started after getting the vaccine), ABDOMINAL PAIN (After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso), COUGH (Recently been coughing), PAIN (The pain moves around, I didnt have it before the vaccine), BACK PAIN (After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso) and PAINFUL RESPIRATION (when breathe it hurts). At the time of the report, PULMONARY PAIN (Pain in lungs, side of lungs to back of lungs), DYSPNOEA (Hard to breathe, started after getting the vaccine), ABDOMINAL PAIN (After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso), COUGH (Recently been coughing), PAIN (The pain moves around, I didnt have it before the vaccine), BACK PAIN (After second dose, went from middle of back to entire left side of abdominal region, top to lower entire torso) and PAINFUL RESPIRATION (when breathe it hurts) had not resolved.            No concomitant medication were provided.  No treatment details were provided  The action taken with mRNA with the events was considered as not applicable.   This case was linked to MOD-2021-278304 (Patient Link).
He provided the lot number GJ5185 for his Paxlovid; He provided the lot number GJ5185 for his Paxlovid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64-year-old male patient received bnt162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "He provided the lot number GJ5185 for his Paxlovid". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 72 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
Headache, Myalgia, Fever, chills, fatigue Narrative:  Myalgia, fever 100.4, headache, chills, fatigue
FULL-BLOWN DIABETES; MYOCARDITIS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. It was unknown whether the adverse event reported following to first dose of vaccine (dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (form of admin, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis.  On an unspecified date, the patient experienced full-blown diabetes, and myocarditis (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the myocarditis and full-blown diabetes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20221034107-covid-19 vaccine ad26.cov2.s-Full blown Diabetes. The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.  20221034107--covid-19 vaccine ad26.cov2.s- Myocarditis- The event(s) has an unknown/unclear temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 9:15 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  On 12-Feb-2021, excursion time was 9 AM, temperature was 29, 10 AM, temperature was 35 and 11 AM temperature was 35. Total doses given for the day was 55, condition of vaccine prior to administration was not frozen. The vial was initially moved to the fridge on 09-Feb-2021 and beyond use date was 10-Mar-2021. 3 vials were sent to clinic on 12-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  No treatment medications were reported.
He developed weakness; Has been bedridden for the last 3 days; Complaining of pain to the arm; This is a spontaneous report from a non-contactable consumer (patients friend) via Pfizer sponsored program support. A male patient of an unspecified age received bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, formulation: solution for injection), via an unspecified route of administration on an unknown date in Jun2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received vaccine about a month ago in 2021. He developed weakness and has been bedridden for the last 3 days in Jun2021 and complaining of pain to the arm in Jun2021. Patient friend considered this an emergency and wants to know what can be done for her friend. There is no PQC reported. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
left arm was numb; face has swollen big time; Eyes immediately becomes red; Left arm was painful; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0171, Expiry date was not reported), via intramuscular route of administration, administered in left arm on 21Jun2021 (at the age of 59-year-old), as dose 1, single for COVID-19 immunization. Medical history included covid-19 from Jun2021 to Jun2021. The patient's concomitant medications were not reported. It was reported that patient got one problem, he test positive for the COVID (Intent: history). Patient waited 10 days. He went to test it again and he tested negative (Further clarification was unknown). The following day (Clarification unknown) he went and got the vaccine, Pfizer first dose that was last Monday, he think 21st and my eyes immediately becomes red. he got home, he stayed home, the following day my left arm was painful but he did not worry much because they told me that will be normal but he went to work Wednesday and he was just working and my left arm was numb and my face has swollen big time and that was numb so he went to the emergency room, they did the test, everything was good so, that is my concern. Yes patient went to the emergency at '9o'clock'. That was in the Baptist hospital, they say everything was good. That was the hospital. You have to call them I do not know. He have given you the information, from there you can call them and find out because he do not know how to read these numbers. The patient was 9095 (incomplete sentence). That was why you have to call. he do not know how to read this thing, Here it says test performed, they did the test on glomerular filtration rate, metabolic panel, BMP, CBC, 'BFT' and 'troponin', Everything was good. FT4, FT3, 'TPO'. (Not appropriately clarified hence not captured in tab). Patient want to report it because he want to see (incomplete sentence) he do not know if he should get the second one and ends with the same thing, get sick. he do not know if he should not try to go to work. The patient underwent lab tests and procedures which included anti-thyroid antibody: unknown, full blood count: good, glomerular filtration rate: good, metabolic function test: good, metabolic function test: good, thyroxine free: unknown, tri-iodothyronine free: unknown, troponin: good all on 23Jun2021 and sars-cov-2 test: positive on Jun2021 and sars-cov-2 test: negative on 20Jun2021. The outcome of the events left arm was numb, face has swollen big time, eyes immediately becomes red, left arm was painful was unknown.   Follow-up attempts are completed. No further information is expected.
Headache, NauseaVomiting, foggy head, injection site soreness, lip numbness  Narrative:
In the AM skin started getting red blotches all over body, in afternoon swelling in the face around eyes and upper lip.
Administered PENTACEL vaccine in error, Patient was supposed to receive KINRIX. No adverse reaction noted. Patients last Hib vaccine was 2006 to complete the 3 series.
Fever  CHILLS, INJECTION SITE PAIN WITH RADIATING HEAT, MALAISE  Narrative:
Transient synovitis of right hip.  Started with limp on 9/29/2011; unable to weight bear on 10/2/2011 and admitted to Hospital 10/2/2011-10/3/2011.  Responded to NSAIDS.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with GARDASIL (lot # K006191, expiration date: 02-FEB-2017, route and dose were not reported). Concomitant drug was not reported. The vaccines were at 29 F for 648 minutes and 55 F for 360 minutes because of date logger issue. There was no previous temperature excursion. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Patient temporarily fainted, and immediately came back, she was sweating,  was given gatorade. Checked her blood pressure it was initially 87/58 at 4:21 pm. Sat with her and  checked pressure again at 4:30 pm, and bp had returned to 113/75.  she was fully recovered by 04:45pm and she left the pharmacy.
Terrible smell in nose; Had a temperature; This is a spontaneous report from a contactable consumer or other non hcp (wife of the patient).   A 75-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered on 10Mar2021 (at the age of 75 years old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included cancer from an unknown date and unknown if ongoing. The patient did not have constipation. The patient's concomitant medications were not reported. The reporter reported that on an unspecified date, the patient experienced terrible smell in nose and had a temperature. The patient had not been tested COVID yet. The patient had a temperature. Also mentioned for like five days he had a smell in his nose. No other symptoms. The patient received the shot on 10Mar2021. The second vaccine would be supposed to be the following Monday on 29Mar2021. The first symptoms started on Monday. He also has chemo and radiation, and it could be related according to caller. The issue that was bothering them was the event related to the smell. He was not losing his sense of smell, he has a smell in his nose that was now less. This started on Monday. The patient underwent lab tests and procedures which included body temperature which results into had a temperature on unspecified date. The outcome for the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.